- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Patients with COPD at Increased Risk of Cognitive Impairment
![Patients with COPD at Increased Risk of Cognitive Impairment Patients with COPD at Increased Risk of Cognitive Impairment](https://medicaldialogues.in/h-upload/2020/12/25/750x450_144719-copd.webp)
COPD is associated with a series of comorbidities, including ischemic heart disease, hypertension, diabetes, lung cancer, and so on. In addition, a large UK population-based study published in the journal respiratory MEDICINE reconfirms that the patients with COPD have an increased incidence of cognitive impairment.
Previous studies suggest that COPD is associated with hypoxemia and cognitive impairment. Cross-sectional studies have also reported a higher frequency of mild cognitive impairment (MCI) in individuals with compared with those without a diagnosis of COPD. In the absence of curative therapy for dementia, the early identification of modifiable risk factors for MCI, the earliest symptomatic phase of dementia, is important for preventing or delaying the onset of cognitive impairment. Researchers of the University of Nottingham, United Kingdom conducted a study to determine the incidence of cognitive impairment and dementia in people with and without a COPD diagnosis.
It was a population-based study using the UK General Practice (GP) health records from The Health Improvement Network database. Researchers identified a total of 2,92,224 patients among which 62,148 were diagnosed with COPD and 230,076 were without COPD. Patients with confirmed COPD diagnosis, ≥40 years old, were matched to up to four subjects without a COPD diagnosis by age, sex and GP practice. Researchers used Cox proportional hazards models to assess the incidence rates of cognitive impairment and dementia.
Key findings of the study were:
♦ Among patients with COPD (n=62,148) researchers observed, 9% developed cognitive impairment, compared with 7% of subjects without COPD (n=230,076).
♦ They also observed that the incidence of cognitive impairment was greater in subjects with COPD than in subjects without COPD following index date (adjusted Hazard Ratio (aHR), 1.21)
♦ After adjusting the confounders, they found a coded incidence of either cognitive impairment or dementia was also greater in patients with COPD (aHR: 1.13).
♦ They reported that coded incident dementia alone was not different between patients with COPD and subjects without COPD (aHR, 0.91)
The authors concluded, "Despite the increased incidence of cognitive impairment in patients with COPD, the incident of dementia was not as frequently recorded in patients with COPD. This raises the concern of undiagnosed dementia and emphasises the need for a systematic assessment in this population".
For further information:
Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: editorial@medicaldialogues.in. Contact no. 011-43720751